News

DelveInsight’s, “Diabetes Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 200+ ...
The Global Metabolism Drugs Market, valued at approximately USD 16.10 billion in 2022, is projected to grow at a robust CAGR of more than 6.50% during the forecast period from 2023 to 2030. Metabolism ...
Studies suggest that some commercially available health tests are inaccurate and unsuitable for public use. Rebecca Coombes , Hristio Boytchev , and Gareth Iacobucci ask if regulation is adequately ...
The global sarcopenia treatment market, valued at approximately USD 3.07 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.48% over the forecast period from 2024 to ...